Exhibit 99.1 July 31, 2007
26220 Enterprise Court        Lake Forest, California 92630        Tel  949.639.2000        Fax  949.587.1850	For Further Information, Contact:                                       Lawrence M. Higby                     Chris A. Karkenny Chief Executive Officer    or        Chief Financial Officer 949.639.4960                                949.639.4990

APRIA HEALTHCARE ANNOUNCES
2007 SECOND QUARTER FINANCIAL RESULTS

        LAKE FOREST, CA… July 31, 2007…Apria Healthcare Group Inc. (NYSE:AHG), one of the nation’s leading home healthcare companies, today announced its financial results for the quarter ended June 30, 2007.

        Revenues were $394.0 million, which represents a 4.8% increase compared to revenues of $376.1 million in the second quarter of 2006. Second quarter 2007 net income was $20.8 million, an increase of 12.8% from $18.5 million in the second quarter of 2006. Current quarter diluted earnings per share were $0.47, which includes a one-time positive impact of $0.01 per share resulting from the settlement of a 2005 tax issue. This compares to $0.43 diluted earnings per share for the comparable prior year period.

        Gross margins were 65.9% in the second quarter of 2007, compared to 65.7% reported in the second quarter of last year.

        Days sales outstanding (DSO) were 48 days at June 30, 2007, down from 52 days at June 30, 2006. This improvement is a direct result of increased cash collections resulting from initiatives to optimize billing processes and to increase patient co-payments. The provision for doubtful accounts as a percentage of revenues was 2.8%, compared to 2.6% in the corresponding period last year.

        Selling, distribution and administrative expenses were 53.1% of revenues, which is flat with the first quarter of 2007 and 0.4% higher compared to 52.7% in the second quarter of last year.

        “We are pleased with our continued strong performance in the second quarter,” said Lawrence M. Higby, Chief Executive Officer. “Growth over the prior year, and sequentially with the first quarter, is encouraging, and our sales force segmentation strategy is gaining traction. The planned expansion of our sales force was primarily responsible for the slight increase in SD&A expenses and, as previously announced, we believe the larger and more focused sales force will contribute to accelerating revenue growth. Operationally, the initiatives we put in place in 2006 and early 2007 in the areas of asset utilization and revenue management continue to show improved results.”

        Earnings before interest, taxes, depreciation and amortization (EBITDA) was $71.4 million in the second quarter of 2007, representing a 2.1% decrease over EBITDA of $72.9 million in the second quarter of 2006. The decrease was due to Medicare cuts and the investments in the Company’s sales force. EBITDA is presented as a supplemental performance measure and is not intended as an alternative to net income or any other measure calculated in accordance with generally accepted accounting principles. Further, EBITDA may not be comparable to similarly titled measures used by other companies. A table reconciling EBITDA to net income is presented at the end of the condensed consolidated financial statements included in this release.

Liquidity and Capital

        Free cash flow was $63.6 million in the second quarter of 2007, compared to $63.3 million in the second quarter of 2006. Contributing to the strong free cash flow was a reduction in capital expenditures and strong cash collections of receivables. Total capital expenditures in the second quarter of 2007 were 5.9% of revenues versus 7.3% in the second quarter of 2006. The reduction in capital expenditures is primarily attributable to initiatives to improve asset utilization.

        During the quarter, the Company reduced its $500 million revolving credit line balance by $55 million. As of June 30, 2007, the outstanding balance on the revolver was $155 million.

        Free cash flow is defined as operating cash flow minus capital expenditures and does not include acquisitions or financing activities. It is presented as a supplemental performance measure and is not intended as an alternative to any other cash flow measure calculated in accordance with generally accepted accounting principles. Further, free cash flow may not be comparable to similarly titled measures used by other companies. A table reconciling free cash flow to cash provided by operating activities is presented at the end of the condensed consolidated financial statements included in this release.

2007 Guidance

        Management affirms its previous estimate of 2007 revenue growth in the 4% to 5% range and net income per share (diluted) of $1.78 to $1.82. The Company’s free cash flow estimate also remains unchanged.

*   *   *

        Apria provides home respiratory therapy, home infusion therapy and home medical equipment through approximately 500 branches serving patients in all 50 states. With over $1.5 billion in annual revenues, it is one of the nation’s leading home healthcare companies.

        This release may contain statements regarding anticipated future developments that are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Results may differ materially as a result of the risk factors included in the Company’s filings with the Securities and Exchange Commission and other factors over which the Company has no control.

*   *   *

(Financial tables attached)

APRIA HEALTHCARE GROUP INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

	June 30,		December 31,
(dollars in thousands)	2007		2006
ASSETS		(unaudited)
CURRENT ASSETS:
Cash and cash equivalents	$	28,483	$	14,657
Accounts receivable, net of allowance for doubtful accounts		211,307		211,097
Inventories, net		38,624		40,681
Other current assets		77,557		78,502
TOTAL CURRENT ASSETS		355,971		344,937
PATIENT SERVICE EQUIPMENT, NET		195,502		212,068
PROPERTY, EQUIPMENT & IMPROVEMENTS, NET		59,807		52,975
OTHER ASSETS, NET		556,075		558,516
TOTAL ASSETS	$	1,167,355	$	1,168,496
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable and accrued liabilities	$	192,986	$	201,378
Current portion of long-term debt		-		2,145
TOTAL CURRENT LIABILITIES		192,986		203,523
LONG-TERM DEBT, net of current portion		405,000		485,000
OTHER NON-CURRENT LIABILITIES		99,448		69,542
TOTAL LIABILITIES		697,434		758,065
STOCKHOLDERS’ EQUITY		469,921		410,431
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	1,167,355	$	1,168,496

APRIA HEALTHCARE GROUP INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(unaudited)

	Three Months Ended June 30,				Six Months Ended June 30,
(dollars in thousands, except per share data)	2007		2006		2007		2006
Respiratory therapy	$	269,440	$	256,289	$	537,712	$	509,437
Infusion therapy		72,297		68,231		141,265		133,003
Home medical equipment/other		52,307		51,559		104,357		101,695
NET REVENUES		394,044		376,079		783,334		744,135
GROSS PROFIT		259,559		247,109		514,053		488,191
Provision for doubtful accounts		11,093		9,737		20,791		19,905
Selling, distribution and administrative expenses		209,406		198,352		415,985		396,045
Amortization of intangible assets		706		1,665		1,698		2,942
OPERATING INCOME		38,354		37,355		75,579		69,299
Interest expense, net		5,000		8,016		10,826		15,303
INCOME BEFORE TAXES		33,354		29,339		64,753		53,996
Income tax expense		12,525		10,881		24,780		19,415
NET INCOME	$	20,829	$	18,458	$	39,973	$	34,581
Income per common share - assuming dilution	$	0.47	$	0.43	$	0.91	$	0.81
Weighted average number of common shares outstanding		44,232		42,789		44,110		42,871

APRIA HEALTHCARE GROUP INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited)

	Six Months Ended June 30,
(dollars in thousands)	2007			2006
OPERATING ACTIVITIES
Net income	$	39,973		$	34,581
Items included in net income not requiring cash:
Provision for doubtful accounts		20,791			19,905
Depreciation and amortization		67,049			70,832
Deferred income taxes, share-based compensation and other		11,350			16,828
Changes in operating assets and liabilities, exclusive of effects of acquisitions		(7,553	)		(13,246	)
NET CASH PROVIDED BY OPERATING ACTIVITIES		131,610			128,900
INVESTING ACTIVITIES
Purchases of patient service equipment and property,
equipment and improvements, exclusive of effects of acquisitions		(55,811	)		(66,264	)
Proceeds from disposition of assets		52			648
Cash paid for acquisitions, including payments of deferred consideration		-			(5,040	)
NET CASH USED IN INVESTING ACTIVITIES		(55,759	)		(70,656	)
FINANCING ACTIVITIES
Net payments on debt		(82,145	)		(58,720	)
Issuances of common stock		16,554			2,873
Other		3,566			6,119
NET CASH USED IN FINANCING ACTIVITIES		(62,025	)		(49,728	)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		13,826			8,516
Cash and cash equivalents at beginning of period		14,657			23,304
CASH AND CASH EQUIVALENTS AT END OF PERIOD	$	28,483		$	31,820

APRIA HEALTHCARE GROUP INC.

CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

RECONCILIATIONS
(unaudited)

	Three Months Ended June 30,						Six Months Ended June 30,
(dollars in thousands)	2007			2006			2007			2006
Reconciliation – EBITDA:      Reported net income	$	20,829		$	18,458		$	39,973		$	34,581
Add back:   Interest expense, net		5,000			8,016			10,826			15,303
Add back:   Income tax expense		12,525			10,881			24,780			19,415
Add back:   Depreciation		32,388			33,926			65,351			67,890
Add back:   Amortization of intangible assets		706			1,665			1,698			2,942
Adjusted EBITDA	$	71,448		$	72,946		$	142,628		$	140,131
Reconciliation – Free Cash Flow:      Net cash provided by operating activities	$	86,721		$	90,737		$	131,610		$	128,900
Less: Purchases of patient service equipment and        property, equipment and improvements, exclusive        of effects of acquisitions		(23,139	)		(27,430	)		(55,811	)		(66,264	)
Free cash flow	$	63,582		$	63,307		$	75,799		$	62,636

#   #   #